Recent advances in the regulation of the TOR pathway by insulin and nutrients

Joseph Avruch*, Yenshou Lin, Xiaomeng Long, Sid Murthy, Sara Ortiz-Vega


研究成果: 雜誌貢獻回顧評介論文同行評審

90 引文 斯高帕斯(Scopus)


Purpose of Review: The aim of this article is to summarize recent advances in the understanding of the regulation of the target of rapamycin (TOR), a protein kinase that is regulated independently by insulin, amino acids and energy sufficiency and which participates in the control of the component of protein synthesis responsible for cell growth. Recent findings: These have been found in two major areas: genetic studies in Drosophila followed by studies in mammalian systems have identified the components of the Tuberous Sclerosis protein complex, a heterodimer of the proteins Hamartin and Tuberin, as inhibitors of TOR signaling, and as the major targets by which the insulin/IGF-1 signal transduction pathway, through the protein kinase PKB, and the energy status of the cell, through the AMP-activated protein kinase, regulate the TOR signaling. In turn, the inhibitory action of the tuberous sclerosis protein complex has been shown to be mediated by its ability to deactivate the small, ras-like GTPase Rheb. A second advance has been achieved by the identification of the TOR-associated protein raptor, as an indispensable substrate binding subunit of the TOR complex, and as the site at which the inhibitory effects on TOR signaling of rapamycin and amino acid deficiency converge. Summary: These findings bring us closer to the understanding of how nutrients and insulin coordinate protein synthesis to regulate anabolic cell growth.

頁(從 - 到)67-72
期刊Current Opinion in Clinical Nutrition and Metabolic Care
出版狀態已發佈 - 2005 1月

ASJC Scopus subject areas

  • 醫藥(雜項)
  • 營養與營養學


深入研究「Recent advances in the regulation of the TOR pathway by insulin and nutrients」主題。共同形成了獨特的指紋。